The Effects of Study Products Containing Varying Quantities of Docosahexaenoic Acid (DHA)
ClinicalTrials.gov ID
NCT01174134
Lead Sponsor
Mead Johnson NutritionINDUSTRY
Overall Status
Completed
Study Type
Interventional
Phase
Not Applicable
Last Update Posted
Sep 2, 2011Estimated
Start Date
Jul 2006
Primary Completion Date
May 2007Actual
Brief Summary
The clinical trial will provide a milk-based drink with constant amounts of nutrients but differing amount of Docosahexaenoic Acid (DHA).
Levels of DHA in the Blood
Nutritional beverage
Ages Eligible for Study
Child (0-17)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
Yes
Eligibility Criteria
Inclusion Criteria:
Participant is 18 to 36 months of age
Participant's current weight and height within the 10th to 90th percentiles
Parent/caregiver reports that participant consumes milk or a milk-based beverage on a daily basis
Participant lives at home with parent(s) or other family member(s)
Signed informed consent and authorization obtained to use and or disclose Protected Health Information (PHI)
Exclusion Criteria:
Participant who is receiving any breast milk at time of randomization
Participant with an active infection.
Participant with a history of underlying disease, chronic disease, or congenital malformation which in the opinion of the Investigator is likely to interfere with the evaluation of the participant.
Known or suspected intolerance to cow's milk protein
Participant diagnosed with diabetes
Participant is from a multiple birth and the sibling(s) are still living
Participant with a sibling that has participated in this study.